Dinutuximab beta | m-entrepreneurship.com

Product Name :
Dinutuximab beta

Search keywords :
Dinutuximab

drugId :
null

Target Vo:
Disialoganglioside GD2

Target Vo Short Name :
GD2

Moa_Name:
Antibody-dependent cell-mediated cytotoxicity (ADCC) effects

First Approval Country :
EU

First Approval Date Filter:
2017

Origin Company_Name :
Apeiron Biologics

Active Company_Name :
Apeiron Biologics

Active Indication_Name:
Neuroblastoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Cyclin E1 Rabbit mAb manufacturer
Tezepelumab (anti-TSLP) web
Cathepsin D Antibody: Cathepsin D Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 45/28 kDa, targeting to Cathepsin D. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts